Icagen, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$41K

135 transactions

Summary

Icagen, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $40KSales: —10 insiders

Date	Insider	Type	Value
2019-08-26	TAGLICH MICHAEL N	A	—
2019-08-26	TAGLICH MICHAEL N	A	—
2019-08-26	TAGLICH ROBERT	A	—
2019-08-26	TAGLICH ROBERT	A	—
2019-04-29	Krafte Douglas(Chief Scientific Officer)	A	$0
2019-04-29	Cunningham, Richard Anthony(Chief Executive Officer)	A	$0
2018-11-14	TYSON TIMOTHY	A	$0
2018-11-14	TYSON TIMOTHY	A	$0
2018-11-14	TAGLICH MICHAEL N	A	$0
2018-11-14	Roffman Edward	A	$0
2018-11-14	Palmieri Vincent	A	$0
2018-11-14	Krafte Douglas(Chief Scientific Officer)	A	$0
2018-11-14	KORB MARK JOHN(Chief Financial Officer)	A	$0
2018-11-14	KABATZNIK CLIVE	A	$0
2018-11-14	Cunningham, Richard Anthony(Chief Executive Officer)	A	$0
2018-08-27	TAGLICH MICHAEL N	A	—
2018-08-27	TAGLICH MICHAEL N	A	—
2018-08-27	TAGLICH ROBERT	A	—
2018-08-27	TAGLICH ROBERT	A	—
2018-08-13	KABATZNIK CLIVE	A	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Icagen, Inc. — Contributions, Lobbying & Contracts | Poliscope